January 26, 2024 – Miami Cancer Institute, part of Baptist Health South Florida, will host its second annual Precision Oncology Symposium from April 19-20, 2024, according to the symposium organizers. This one-and-a-half-day symposium, to be held in Miami, FL has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas, and brain tumors — by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.

“Our goal has always been clear – to build on President Biden’s moonshot initiative to decrease cancer mortality by 50% in the next 25 years. To get to this point, we need to bring physicians and researchers together to educate one another on the progress we’ve made. Collectively, we can continue advancing our progress to more innovative therapies and a greater quality of life for all cancer patients,” shared Manmeet Ahluwalia, M.D., M.B.A., FASCO, the symposium’s director as well as Fernandez Family Foundation Endowed Chair in Cancer Research, Chief of Medical Oncology, Chief Scientific Officer, and Deputy Director of Miami Cancer Institute.

This symposium will center around the advancements made in the precision oncology sector, spanning across distinct disease areas.  “Precision oncology is the future of cancer treatment. By understanding the patient’s molecular make up and using it to design the most appropriate treatment plan, we can provide patients the best opportunity for cure,” shared Dr. Ahluwalia.

To learn more about the symposium or to directly register, visit MiamiCancerInstitute.com/PrecisionOncology

About Miami Cancer Institute

Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute

Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches. Baptist Health South Florida is an academic and clinical affiliate of Florida International University Herbert Wertheim College of Medicine.

Post Views: 3